Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation

Cited by (563)

Items 101–200 of 563

1. Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
   Megen C Wittling, Shannon R. Cahalan, Eric A. Levenson, Ronald L. Rabin · 2021 · Frontiers in Immunology
2. ISG15 Is Upregulated in Respiratory Syncytial Virus Infection and Reduces Virus Growth through Protein ISGylation
   Rubén González-Sanz, Manuel Mata, Jesús F. Bermejo-Martín, Amparo Álvarez, Julio Cortijo, José Antonio Melero, Isidoro Martínez · 2016 · Journal of Virology
3. Structure and Function of Viral Deubiquitinating Enzymes
   Ben A. Bailey-Elkin, Robert C. M. Knaap, Marjolein Kikkert, Brian L. Mark · 2017 · Journal of Molecular Biology
4. Impaired IL-23–dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency
   Masato Ogishi, Andrés Augusto Arias, Rui Yang, Ji Eun Han, Peng Zhang, Darawan Rinchai, Joshua Halpern, Jeanette Mulwa, Narelle Keating, Maya Chrabieh et al. · 2022 · The Journal of Experimental Medicine
5. In Vivo RNAi Screening Identifies MDA5 as a Significant Contributor to the Cellular Defense against Influenza A Virus
   Asiel Arturo Benitez, Maryline Panis, Jia Xue, Andrew Varble, Jaehee V. Shim, Amy L. Frick, Carolina B. López, David M Sachs, Benjamin Robert tenOever · 2015 · Cell Reports
6. Irreversible inactivation of ISG15 by a viral leader protease enables alternative infection detection strategies
   Kirby N. Swatek, Martina Aumayr, Jonathan N. Pruneda, Linda J. Visser, Stephen Berryman, Anja F. Kueck, Paul P. Geurink, Huib Ovaa, Frank J. M. van Kuppeveld, Tobias J. Tuthill et al. · 2018 · Proceedings of the National Academy of Sciences
7. HDAC stimulates gene expression through BRD4 availability in response to IFN and in interferonopathies
   Isabelle J. Marié, Hao-Ming Chang, David E. Levy · 2018 · The Journal of Experimental Medicine
8. Posttranslational Modification as a Critical Determinant of Cytoplasmic Innate Immune Recognition
   Paul J. Baker, Dominic De Nardo, Fiona Moghaddas, Le Son Tran, Annabell Bachem, Tan A. Nguyen, Thomas J. Hayman, Hazel Tye, James Edward Vince, Sammy Bedoui et al. · 2017 · Physiological Reviews
9. Consecutive Inhibition of ISG15 Expression and ISGylation by Cytomegalovirus Regulators
   Ye Ji Kim, Eui Tae Kim, Young-Eui Kim, Myoung Kyu Lee, Ki Mun Kwon, Keun Il Kim, Thomas Stamminger, Jin‐Hyun Ahn · 2016 · PLoS Pathogens
10. ISGylation in Innate Antiviral Immunity and Pathogen Defense Responses: A Review
    Mengdi Zhang, Jingxian Li, Haiyan Yan, Jun Huang, Fangwei Wang, Ting Liu, Linghui Zeng, Fangfang Zhou · 2021 · Frontiers in Cell and Developmental Biology
11. Origins and immunopathogenesis of autoimmune central nervous system disorders
    Sudarshini Ramanathan, Fabienne Brilot, Sarosh R. Irani, Russell Clive Dale · 2023 · Nature Reviews Neurology
12. A Four-Biomarker Blood Signature Discriminates Systemic Inflammation Due to Viral Infection Versus Other Etiologies
    Dayle L. Sampson, Brian A. Fox, Thomas D. Yager, S. Bhide, Silvia Cermelli, Leo C. McHugh, Therese A. Seldon, Roslyn A. Brandon, Erin M. Sullivan, Jerry J. Zimmerman et al. · 2017 · Scientific Reports
13. The E3 ubiquitin ligase ARIH1 promotes antiviral immunity and autoimmunity by inducing mono-ISGylation and oligomerization of cGAS
    Tian-Chen Xiong, Mingcong Wei, Fangxu Li, Miao Shi, Hu Gan, Zhen Tang, Hong‐Peng Dong, Tianzi Liuyu, Pu Gao, Bo Zhong et al. · 2022 · Nature Communications
14. Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs
    Jean‐Laurent Casanova, Mark Stuart Anderson · 2023 · Journal of Clinical Investigation
15. Lymph Node Macrophages Restrict Murine Cytomegalovirus Dissemination
    Helen E. Farrell, Nicholas J. Davis-Poynter, Kimberley L. Bruce, Clara Lawler, Lars Dölken, Michael Mach, Philip G. Stevenson · 2015 · Journal of Virology
16. Dysfunction in protein clearance by the proteasome: impact on autoinflammatory diseases
    Anja Brehm, Elke Krüger · 2015 · Seminars in Immunopathology
17. Emerging Roles of USP18: From Biology to Pathophysiology
    Ji An Kang, Young Joo Jeon · 2020 · International Journal of Molecular Sciences
18. ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma
    Ren-Hui Chen, Yong Du, Ping Han, Hong-Bo Wang, Faya Liang, Guo‐Kai Feng, Ai-Jun Zhou, Mu-Yan Cai, Qian Zhong, Mu‐Sheng Zeng et al. · 2016 · Oncotarget
19. How ISG15 combats viral infection
    Brendan T. Freitas, Florine E. M. Scholte, Éric Bergeron, Scott D. Pegan · 2020 · Virus Research
20. Human life within a narrow range: The lethal ups and downs of type I interferons
    Yanick Joseph Crow, Jean‐Laurent Casanova · 2024 · Science Immunology
21. Interferon-stimulated gene 15 accelerates replication fork progression inducing chromosomal breakage
    Maria Chiara Raso, Nikola Djoric, Franziska Walser, Sandra Hess, Fabian Marc Schmid, Sibylle Burger, Klaus‐Peter Knobeloch, Lorenza Penengo · 2020 · The Journal of Cell Biology
22. Lessons learned from the study of human inborn errors of innate immunity
    Giorgia Bucciol, Leen Moens, Barbara Bosch, Xavier Bossuyt, Jean‐Laurent Casanova, Anne Puel, Isabelle Meyts · 2018 · Journal of Allergy and Clinical Immunology
23. Strategies to Target ISG15 and USP18 Toward Therapeutic Applications
    Daniel J. Fernandez, Sandra Hess, Klaus‐Peter Knobeloch · 2020 · Frontiers in Chemistry
24. Type I Interferon Regulates a Coordinated Gene Network to Enhance Cytotoxic T Cell–Mediated Tumor Killing
    Jun-Bao Fan, Sayuri Miyauchi, Huizhong Xu, Dan Liu, Leo J.Y. Kim, Christoph Burkart, Hua Cheng, Kei‐ichiro Arimoto, Ming Yan, Yu Zhou et al. · 2020 · Cancer Discovery
25. More than Meets the ISG15: Emerging Roles in the DNA Damage Response and Beyond
    Zac Sandy, Isabelle Cristine da Costa, Christine K. Schmidt · 2020 · Biomolecules
26. Evaluation and validation of an RT‐PCR assay for specific detection of monkeypox virus (MPXV)
    Alberto Paniz‐Mondolfi, Susana Guerra, Marina Muñoz, Nicolás Luna, Matthew M. Hernandez, Luz Helena Patiño, Jason Reidy, Radhika Banu, Paras Shrestha, Bernadette Liggayu et al. · 2022 · Journal of Medical Virology
27. Microglial Interferon Signaling and White Matter
    Ashley McDonough, Richard V. Lee, Jonathan R. Weinstein · 2017 · Neurochemical Research
28. Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19
    Valentino Clemente, Pádraig D’Arcy, Martina Bazzaro · 2020 · International Journal of Molecular Sciences
29. Network Analysis Identifies Proinflammatory Plasma Cell Polarization for Secretion of ISG15 in Human Autoimmunity
    Matthew A. Care, Sophie Stephenson, Nicholas A Barnes, Im Fan, Alexandre Zougman, Yasser Mohamed El-Sherbiny, Edward M J Vital, David R. Westhead, Reuben M. Tooze, Gina M. Doody · 2016 · The Journal of Immunology
30. Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity
    Adán Pinto-Fernández, Mariolina Salio, Tom Partridge, Jianzhou Chen, George Vere, Helene Greenwood, Cyriel Sebastiaan Olie, Andreas Damianou, Hannah Claire Scott, Henry J. Pegg et al. · 2020 · British Journal of Cancer
31. Regulation of human interferon signaling by transposon exonization
    Giulia Irene Maria Pasquesi, Holly L. Allen, Atma M. Ivancevic, Arturo Barbachano-Guerrero, Olivia Joyner, Kejun Guo, David M. Simpson, Keala Gapin, Isabella Horton, Lily L. Nguyen et al. · 2024 · Cell
32. The liver as a central "hub" of the immune system: pathophysiological implications
    Ronca, Vincenzo, Gerussi, Alessio, Collins, Paul, Parente, Alessandro, Oo, Ye Htun, Invernizzi, Pietro · 2025 · Physiological Reviews
33. IFNA2: The prototypic human alpha interferon
    Franciane Paul, Sandra Pellegrini, Gilles Uzé · 2015 · Gene
34. Interferon-Driven Immune Dysregulation in Down Syndrome: A Review of the Evidence
    Howard Chung, Peter H R Green, Timothy Cragin Wang, Xiao‐Fei Kong · 2021 · Journal of Inflammation Research
35. Type I interferon dysregulation and neurological disease
    Sarah L. McGlasson, Alexa Jury, Andrew P. Jackson, David P J Hunt · 2015 · Nature Reviews Neurology
36. CRISPR/Cas9 knockout of USP18 enhances type I IFN responsiveness and restricts HIV-1 infection in macrophages
    Jared P. Taylor, Melanie N. Cash, Katherine E. Santostefano, Mahito Nakanishi, Naohiro Terada, Mark A. Wallet · 2018 · Journal of Leukocyte Biology
37. Ubiquitin-like Molecule ISG15 Acts as an Immune Adjuvant to Enhance Antigen-specific CD8 T-cell Tumor Immunity
    Daniel O. Villarreal, Megan C. Wise, Rebekah J Siefert, Jian Yan, Laurence M. Wood, David B. Weiner · 2015 · Molecular Therapy
38. Novirhabdoviruses versus fish innate immunity: A review
    Mei He, Nai‐Zheng Ding, Cheng-Qiang He · 2021 · Virus Research
39. Early IFN type I response: Learning from microbial evasion strategies
    Eliana Marina Coccia, Angela Battistini · 2015 · Seminars in Immunology
40. RIG-I regulates myeloid differentiation by promoting TRIM25-mediated ISGylation
    Songfang Wu, Xia Li, Xiaodong Shi, Yu‐Jun Dai, Wei-Na Zhang, Jun-Mei Zhao, Wu Zhang, Xiangqin Weng, Jing Lu, Huangying Le et al. · 2020 · Proceedings of the National Academy of Sciences
41. Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease
    Ana Esteve‐Solé, Ithaisa Sologuren, María T. Martínez-Saavedra, Àngela Deyà‐Martínez, Carmen Oleaga‐Quintas, Rubén Martínez‐Barricarte, Andrea Martín‐Nalda, Manel Juan, Jean‐Laurent Casanova, Carlos Rodríguez‐Gallego et al. · 2018 · Critical Reviews in Clinical Laboratory Sciences
42. Fine-tuning of type I IFN-signaling in microglia — implications for homeostasis, CNS autoimmunity and interferonopathies
    Tobias Goldmann, Thomas Blank, Marco Prinz · 2015 · Current Opinion in Neurobiology
43. The impact of ISGylation during Mycobacterium tuberculosis infection in mice
    Jacqueline M. Kimmey, Jessica A. Campbell, Leslie A. Weiss, Kristen J. Monte, Deborah J. Lenschow, Christina L. Stallings · 2017 · Microbes and Infection
44. Mycobacterial diseases in patients with inborn errors of immunity
    Stéphanie Boisson‐Dupuis, Jacinta C. Bustamante · 2021 · Current Opinion in Immunology
45. Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency
    Florian Gothe, Jarmila Stremenova Spegarova, Catherine F. Hatton, Helen R Griffin, Thomas Sargent, Sally A. Cowley, William James, Anna Roppelt, Anna Yu. Shcherbina, Fabian H. Hauck et al. · 2022 · Journal of Allergy and Clinical Immunology
46. Selective Autophagy by Close Encounters of the Ubiquitin Kind
    Anna Vainshtein, Paolo Grumati · 2020 · Cells
47. Genetics and molecular biology of brain calcification
    Hao Deng, Wen Li Zheng, Joseph J. Jankovic · 2015 · Ageing Research Reviews
48. Myogenic Progenitor Cells Exhibit Type I Interferon–Driven Proangiogenic Properties and Molecular Signature During Juvenile Dermatomyositis
    Cyril Gitiaux, Claire Latroche, Michèle Weiss‐Gayet, Mathieu Paul Rodero, Darragh Duffy, Brigitte Bader‐Meunier, Christophe Glorion, Patrick Nusbaum, Christine Bodemer, Guy Mouchiroud et al. · 2017 · Arthritis & Rheumatology
49. ISG15 secretion exacerbates inflammation in SARS-CoV-2 infection
    Xuetao Cao · 2021 · Nature Immunology
50. Decoupling deISGylating and deubiquitinating activities of the MERS virus papain-like protease
    Jozlyn R. Clasman, Renata K. Everett, Karthik Srinivasan, Andrew D. Mesecar · 2019 · Antiviral Research
51. Clinical and Molecular Findings in Mendelian Susceptibility to Mycobacterial Diseases: Experience From India
    Prasad D. Taur, Vijaya Gowri, Ambreen Abdulwahab Pandrowala, Vaishnavi Venkatachari Iyengar, Akshaya Sanjay Chougule, Zainab Mohammedi Golwala, Shraddha Chandak, Reepa Agarwal, Purva Keni, Neha Dighe et al. · 2021 · Frontiers in Immunology
52. Interferon-stimulated gene 15 pathway is a novel mediator of endothelial dysfunction and aneurysms development in angiotensin II infused mice through increased oxidative stress
    María González‐Amor, Ana B. García‐Redondo, Inmaculada Jorge, Guillermo Zalba, Martina Bécares, María Jesús Ruiz-Rodríguez, Cristina Rodrı́guez, Hugo Bermeo, Raquel Rodrigues‐Díez, Francisco J. O. Rios et al. · 2021 · Cardiovascular Research
53. Protein modification with ISG15 blocks coxsackievirus pathology by antiviral and metabolic reprogramming
    Meike Kespohl, Clara Bredow, Karin Klingel, Martin Voß, Anna Paeschke, Martin Zickler, Wolfgang C. Poller, Ziya Kaya, Johannes Eckstein, Henry Fechner et al. · 2020 · Science Advances
54. Pathogenic insights from genetic causes of autoinflammatory inflammasomopathies and interferonopathies
    Bin Lin, Raphaela T. Goldbach‐Mansky · 2021 · Journal of Allergy and Clinical Immunology
55. Type I interferonopathies—an expanding disease spectrum of immunodysregulation
    Min Ae Lee‐Kirsch, Christine Wolf, Stefanie Kretschmer, Axel Roers · 2015 · Seminars in Immunopathology
56. Monogenic Autoinflammatory Diseases: State of the Art and Future Perspectives
    Giulia Di Donato, Debora Mariarita d’Angelo, Luciana Breda, Francesco Chiarelli · 2021 · International Journal of Molecular Sciences
57. ISG15: its roles in SARS-CoV-2 and other viral infections
    Lucky Sarkar, Guanqun Liu, Michaela U. Gack · 2023 · Trends in Microbiology
58. New monogenic autoinflammatory diseases—a clinical overview
    Scott Canna, Raphaela T. Goldbach‐Mansky · 2015 · Seminars in Immunopathology
59. ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication
    Harini Sooryanarain, Adam J. Rogers, Dianjun Cao, Mary Etna Haac, Yogesh A. Karpe, Xiang‐Jin Meng · 2017 · Journal of Virology
60. LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer
    Pang‐Kuo Lo, Yuan Yao, Ji Shin Lee, Yongshu Zhang, Weiliang Huang, Maureen A. Kane, Qun Yong Zhou · 2018 · eLife
61. ISG15, a Small Molecule with Huge Implications: Regulation of Mitochondrial Homeostasis
    Manuel Albert, Martina Bécares, Michela Falqui, Carlos Fernandez-Lozano, Susana Guerra · 2018 · Viruses
62. Posttranslational ISGylation of NLRP3 by HERC enzymes facilitates inflammasome activation in models of inflammation
    Ying Qin, Xintong Meng, Mengge Wang, Wenbo Liang, Rong Xu, Jingchunyu Chen, Hui Song, Yue Fu, Jingxin Li, Chengjiang Gao et al. · 2023 · Journal of Clinical Investigation
63. Microparticles released from Mycobacterium tuberculosis‐infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15
    Nathan J. Hare, Brian Chan, E. D. Chan, Kimberley L. Alexander, Warwick J. Britton, Bernadette M. Saunders · 2015 · PROTEOMICS
64. ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system
    Chaohui Zuo, Xinyi Sheng, Min Ma, Man Xia, Linda Ouyang · 2016 · Oncotarget
65. Perspectives and Advances in the Understanding of Tuberculosis
    Rachel L. Kinsella, Dennis X. Zhu, Gregory A. Harrison, Anne E. Mayer Bridwell, Jerome Prusa, Sthefany M. Chavez, Christina L. Stallings · 2021 · Annual Review of Pathology Mechanisms of Disease
66. Emerging concepts and treatments in autoinflammatory interferonopathies and monogenic systemic lupus erythematosus
    Raphaela T. Goldbach‐Mansky, Sara Alehashemi, Adriana A. de Jesus · 2024 · Nature Reviews Rheumatology
67. Type I Interferonopathies: from a Novel Concept to Targeted Therapeutics
    Isabelle Melki, Marie‐Louise Frémond · 2020 · Current Rheumatology Reports
68. Excessive negative regulation of type I interferon disrupts viral control in individuals with Down syndrome
    Louise Malle, Marta Martín-Fernández, Sofija Buta, Ashley Richardson, Douglas Scott Bush, Dusan Bogunovic · 2022 · Immunity
69. Proteomics Mapping of the ISGylation Landscape in Innate Immunity
    Fabien Théry, Denzel Eggermont, Francis Impens · 2021 · Frontiers in Immunology
70. HDAC7-mediated control of tumour microenvironment maintains proliferative and stemness competence of human mammary epithelial cells
    Cutano, Valentina, Di Giorgio, Eros, Minisini, Martina, Picco, Raffaella, Dalla, Emiliano, Brancolini, Claudio · 2019 · Molecular Oncology
71. ISG15 targets glycosylated PD-L1 and promotes its degradation to enhance antitumor immune effects in lung adenocarcinoma
    Tongyuan Qu, Wenshuai Zhang, Chenhui Yan, Danyang Ren, Yalei Wang, Yuhong Guo, Qianru Guo, Jinpeng Wang, Liren Liu, Lei Han et al. · 2023 · Journal of Translational Medicine
72. Restriction of Human Cytomegalovirus Replication by ISG15, a Host Effector Regulated by cGAS-STING Double-Stranded-DNA Sensing
    Christopher Bianco, Ian Mohr · 2017 · Journal of Virology
73. The Functional Roles of ISG15/ISGylation in Cancer
    Yuan Yin, Hai Qin, Huilong Li, Wanjin Shi, Lichen Bao, Shengtao Xu, Jun Yin, Lufeng Zheng · 2023 · Molecules
74. Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling
    Li Lin, Qingsong Lei, Shujun Zhang, Lingna Kong, Bo Qin · 2016 · PLoS ONE
75. ISG15 expression correlates with HIV-1 viral load and with factors regulating T cell response
    Carolina Scagnolari, Katia Monteleone, Carla Selvaggi, Alessandra Pierangeli, Gabriella d’Ettorre, Ivano Mezzaroma, Ombretta Turriziani, Massimo Gentile, Vincenzo Vullo, Guido Antonelli · 2015 · Immunobiology
76. The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus
    Shuaihantian Luo, Yunuo Wang, Ming Zhao, Qianjin Lu · 2016 · International Immunopharmacology
77. Brain Calcifications: Genetic, Molecular, and Clinical Aspects
    Edoardo Monfrini, Federica Arienti, Paola Rinchetti, Francesco Lotti, Giulietta Maria Riboldi · 2023 · International Journal of Molecular Sciences
78. Unveiling the Multifaceted Roles of ISG15: From Immunomodulation to Therapeutic Frontiers
    Enrique Álvarez, Michela Falqui, Laura Sin, Joseph Patrick McGrail, Beatriz Perdiguero, Rocío Coloma, Laura Marcos-Villar, Céline Tárrega, Mariano Estéban, Carmen Elena Gómez et al. · 2024 · Vaccines
79. Genetic, immunologic, and clinical features of 830 patients with Mendelian susceptibility to mycobacterial diseases (MSMD): A systematic review
    Armin Khavandegar, Seyed Alireza Mahdaviani, Majid Zaki‐Dizaji, Fereshteh Khalili-Moghaddam, Sarina Ansari, Saba Alijani, Nooshin Taherzadeh-Ghahfarokhi, Davood Mansouri, Jean‐Laurent Casanova, Jacinta C. Bustamante et al. · 2024 · Journal of Allergy and Clinical Immunology
80. Cell-Intrinsic Adaptation Arising from Chronic Ablation of a Key Rho GTPase Regulator
    Berati Cerikan, Ranad Shaheen, Georgina P. Coló, Christine Gläßer, Shoji Hata, Klaus‐Peter Knobeloch, Fowzan Sami Alkuraya, Reinhard Fässler, Elmar Schiebel · 2016 · Developmental Cell
81. Does type-I interferon drive systemic autoimmunity?
    Cécile Picard, Alexandre Bélot · 2017 · Autoimmunity Reviews
82. Genetic interferonopathies: An overview
    Despina Eleftheriou, Paul A. Brogan · 2017 · Best Practice & Research Clinical Rheumatology
83. Interferon-stimulated gene 15 modulates cell migration by interacting with Rac1 and contributes to lymph node metastasis of oral squamous cell carcinoma cells
    Yu-Lin Chen, Wan‐Lin Wu, Chuan‐Wei Jang, Yi‐Chen Yen, Ssu-Han Wang, Fang‐Yu Tsai, Ya‐Wen Chen, Ya‐Wen Chen · 2019 · Oncogene
84. ISG15–USP18 Dysregulation by Oxidative Stress Promotes IFN-γ Secretion from CD8+ T Cells in Vitiligo
    Eun Jung Lee, Do Young ‍Kim, Joo Hye Yeo, Sujin Park, Yu Jeong Bae, Il Joo Kwon, Seol Hwa Seong, Jinu Lee, Sang Ho Oh · 2023 · Journal of Investigative Dermatology
85. Genetics of movement disorders in the next‐generation sequencing era
    Simone Olgiati, Marialuisa Quadri, Vincenzo Bonifati · 2016 · Movement Disorders
86. USP18 and ISG15 coordinately impact on SKP2 and cell cycle progression
    Françoise Vuillier, Zhi Li, Pierre‐Henri Commère, Lasse Toftdal Dynesen, Sandra Pellegrini · 2019 · Scientific Reports
87. Characterization of samhd1 Morphant Zebrafish Recapitulates Features of the Human Type I Interferonopathy Aicardi-Goutières Syndrome
    Paul R. Kasher, Emma M. Jenkinson, Valérie Briolat, David G. Gent, Catherine Morrissey, Leo A. H. Zeef, Gillian Rice, Jean‐Pierre Levraud, Yanick Joseph Crow · 2015 · The Journal of Immunology
88. Monogenic autoinflammatory diseases: Cytokinopathies
    Fiona Moghaddas, Seth Lucian Masters · 2015 · Cytokine
89. Immunoinflammatory diseases of the central nervous system – the tale of two cytokines
    Markus J. Hofer, Iain Leslie Campbell · 2015 · British Journal of Pharmacology
90. Toward a better understanding of type I interferonopathies: a brief summary, update and beyond
    Zhongxun Yu, Hongmei Song · 2019 · World Journal of Pediatrics
91. Exploring the shared molecular mechanisms between systemic lupus erythematosus and primary Sjögren’s syndrome based on integrated bioinformatics and single-cell RNA-seq analysis
    Yanling Cui, Huina Zhang, Zhen Wang, Bangdong Gong, Hisham Al-Ward, Yaxuan Deng, Orion R. Fan, Junbang Wang, Wenmin Zhu, Yi Eve Sun · 2023 · Frontiers in Immunology
92. Insights into the ISG15 transfer cascade by the UBE1L activating enzyme
    Iona Wallace, Kheewoong Baek, Jesuraj Rajan Prabu, Ronnald Vollrath, Susanne von Gronau, Brenda Arlene Schulman, Kirby N. Swatek · 2023 · Nature Communications
93. The Role of Interferon in Persistent Viral Infection: Insights from Murine Norovirus
    Timothy J. Nice, Bridget A. Robinson, Jacob A. Van Winkle · 2017 · Trends in Microbiology
94. The Goldilocks Zone of Type I IFNs: Lessons from Human Genetics
    Justin D. Taft, Dusan Bogunovic · 2018 · The Journal of Immunology
95. Mendelian susceptibility to mycobacterial diseases: state of the art
    Kosuke Noma, Yoko Mizoguchi, Miyuki Tsumura, Satoshi Okada · 2022 · Clinical Microbiology and Infection
96. Congenital deficiency reveals critical role of ISG15 in skin homeostasis
    Muhammad Nasir Hayat Malik, Syed Fakhar-ul-Hassnain Waqas, Jana Zeitvogel, Jingyuan Cheng, Robert Geffers, Zeinab Abu-Elbaha Gouda, Ahmed Elsaman, Ahmed R. Radwan, Matthias Schefzyk, Peter Braubach et al. · 2021 · Journal of Clinical Investigation
97. Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical and Genetic Features of 32 Iranian Patients
    Seyed Alireza Mahdaviani, Davood Mansouri, Mahnaz Jamee, Majid Zaki‐Dizaji, Karim Rahimi Aghdam, Esmaeil Mortaz, MirHojjat Khorasanizadeh, Mahsa Eskian, Mahshid Movahedi, Hosseinali Ghaffaripour et al. · 2020 · Journal of Clinical Immunology
98. Dissecting distinct proteolytic activities of FMDV Lpro implicates cleavage and degradation of RLR signaling proteins, not its deISGylase/DUB activity, in type I interferon suppression
    Linda J. Visser, Chiara Aloise, Kirby N. Swatek, Gisselle N. Medina, Karin M. Olek, Huib H. Rabouw, Raoul J. de Groot, Martijn A. Langereis, Teresa de los Santos, David Komander et al. · 2020 · PLoS Pathogens
99. Deciphering the genetic control of gene expression following Mycobacterium leprae antigen stimulation
    Jérémy Manry, Yohann Nédélec, Vinicius M. Fava, Aurélie Cobat, Marianna Orlova, Nguyen Van Thuc, Vu Hong Thai, Guillaume Laval, Luis Bruno Barreiro, Erwin Schurr · 2017 · PLoS Genetics
100. Inherited Autoinflammatory Syndromes
     Julia E. Rood, Edward M. Behrens · 2021 · Annual Review of Pathology Mechanisms of Disease